NASALIN trademark

NASALIN - Trademark Information

Trademark by CALIFORNIA BIOTECHNOLOGY INC.

The NASALIN trademark was assigned a Serial Number #73516382 – by the United States Patent and Trademark Office (USPTO). Trademark Serial Number is a unique ID to identify the NASALIN mark in USPTO. The NASALIN mark is filed in the category of Pharmaceuticals. The legal correspondent for NASALIN trademark is KATE H MURASHIGE, CIOTTI & MURASHIGE, STE 102, 800 MENLO AVE, MENLO PARK, CALIFORNIA UNITED STATES 94025-4732 Domestic Representative - Not Found Prosecution History Date Description Proceeding Number Dec. 16, 1986 INADVERTENTLY . The current status of the NASALIN filing is Abandoned after publication because applicant filed an express abandonment..

Based on CALIFORNIA BIOTECHNOLOGY INC., the NASALIN trademark is used in the following business: INTRANASAL INSULIN.

TrademarkTok is the largest free online trademark search, trademark monitoring, and tracking platform. We provide online software to streamline the process, helping clients do trademark & patent searches, applications, and monitoring more automatically and efficiently. You can create a free account on TrademarkTok.com and monitor all of your trademarks from one convenient dashboard, and receive free status updates any time when the status is changed.

Have a Name, Slogan, or Logo to protect? TrademarkTok, an Experienced IP Agent Made It Easy - Trademark Registration in 180 Countries.

Set up your brands for success! The United States is the most difficult country in the world to register a trademark. The trademark process in the United States takes approximately one year and is fraught with pitfalls. Approximately 60% of all applications receive a refusal. Many of these refusals can be overcome by strategic work of an experienced IP consultant, but DIY-applications generally are NOT successful.

We have extensive expertise in intellectual property law, including but not limited to trademark, copyright, and patent matters in multiple countries. You can count on our vast experience in filing trademark applications and trademark maintenance to help get your trademark protected properly, cost-effectively and efficiently.

Select the Filing Country:

Trademark Registration in USA

$199

$199 + Govt Fee* (1 class)

STANDARD PACKAGE

Basic Direct-Hit Searchto help avoid obvious duplications of pre-existing marks.
Professional Preparationof your trademark application.
Electronic Deliveryof your trademark application with no need to wait for mail or dealing with paper files. This will qualify you the reduced government filing fee.
Free Search & Evaluation on Alternative Mark if Your Attorney Thinks There's an Issue with Your First Choice.

* The Trademark government fee will be charged when we submit your mark(s) to the Government Trademark Office, which is usually in the next few business days.

SERIAL NUMBER
73516382
WORD MARK
NASALIN
CURRENT STATUS
Abandoned after publication because applicant filed an express abandonment.
STATUS DATE
Monday, May 12, 1986
FILING DATE
Monday, January 07, 1985
PRIORITY-CLAIM INTERNATIONAL FILING DEADLINE:

July 07, 1985
(PRIORITY CLAIM MUST BE FILED WITHIN SIX MONTHS OF FOREIGN FILING)
Trademarks are territorial. US trademark registration will not protect your trademark in a foreign country. If you have plan to protect your trademark internationally, see more options below :
REGISTRATION NUMBER
N/A
REGISTER TYPE
Principal
TRADEMARK OWNER
2450 BAYSHORE FRONTAGE ROAD, MOUNTAIN VIEW, CALIFORNIA, UNITED STATES, 94043
Owner Type: CORPORATION
TRADEMARK CORRESPONDENT
CIOTTI & MURASHIGE, STE 102, 800 MENLO AVE, MENLO PARK, CALIFORNIA UNITED STATES 94025-4732 Domestic Representative - Not Found Prosecution History Date Description Proceeding Number Dec. 16, 1986 INADVERTENTLY
Trademark Classification Information
CLASS INFO
Class 005 - Pharmaceuticals

First Use Anywhere:
First Use in Commerce:
Trademark Goods and Services Description
DESCRIPTION
Class 005 - INTRANASAL INSULIN

Start Trademark Search

Search Now

Current Status:

Abandoned after publication because applicant filed an express abandonment.

5/12/1986